Quality of life in Klinefelter patients on testosterone replacement therapy compared to healthy controls: an observational study on the impact of psychological distress, personality traits, and coping strategies.
Adaptation, Psychological
/ physiology
Adult
Cognition
Hormone Replacement Therapy
/ methods
Humans
Italy
/ epidemiology
Klinefelter Syndrome
/ epidemiology
Male
Mental Health
Mental Status and Dementia Tests
Personality Assessment
Psychological Distress
Quality of Life
Sexual Behavior
Testosterone
/ therapeutic use
Coping strategies
Genetic disorder
Klinefelter syndrome
Personality traits
Quality of life
Testosterone replacement therapy
Journal
Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
11
06
2020
accepted:
18
08
2020
pubmed:
1
9
2020
medline:
16
11
2021
entrez:
1
9
2020
Statut:
ppublish
Résumé
We aimed to verify if 1 year-testosterone-replacement therapy could produce a psychopathological recovery and a satisfactory quality of life in Klinefelter syndrome (KS) patients compared to matched healthy controls. Further, we analyzed personality traits and coping strategies, an issue not yet examined in androgen-treated KS patients. We also enquired whether any of the sociodemographic and psychological variables might predict a patient's general and sexual life satisfaction. The Quality of Life Enjoyment and Satisfaction Questionnaire and the Temperament and Character Inventory-Revised were administered to both 23 KS patients and matched healthy subjects. Psychopathology was investigated by the Symptom Checklist-90-Revised (SCL-90-R) and the Mini-mental State Examination. The COPE Inventory was used to identify cognitive and behavioral strategies to manage disease-related distress. In testosterone-treated KS patients, when compared with controls, SCL-90-R subscales analysis evidenced high psychological distress, mainly presented as obsessive thoughts, hanger-hostility, phobias, and psychoticism. Self-directedness and self-transcendence, along with the prevalent use of emotion-focused coping strategies, outlined the personality of our KS patients. Depression and somatization proved to be predictors of general life dissatisfaction. Depression, anger-hostility, and paranoid ideation, instead, emerged as predictors of sexual life dissatisfaction. Endocrinologists should cooperate with mental health providers to foster a better outcome of the disease in KS patients.
Identifiants
pubmed: 32865776
doi: 10.1007/s40618-020-01400-8
pii: 10.1007/s40618-020-01400-8
pmc: PMC8049912
doi:
Substances chimiques
Testosterone
3XMK78S47O
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1053-1063Références
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Sex Med. 2007 Jul;4(4 Pt 1):1056-69
pubmed: 17627750
J Endocrinol Invest. 2015 Jan;38(1):103-12
pubmed: 25384570
PLoS One. 2018 Nov 9;13(11):e0206932
pubmed: 30412595
Eur J Endocrinol. 2009 Mar;160(3):465-8
pubmed: 19131504
J Clin Endocrinol Metab. 2000 Aug;85(8):2839-53
pubmed: 10946892
Endocr Rev. 2018 Aug 1;39(4):389-423
pubmed: 29438472
J Clin Endocrinol Metab. 2006 Apr;91(4):1423-7
pubmed: 16403821
Patient Educ Couns. 2013 Nov;93(2):248-54
pubmed: 23993396
Br J Psychiatry. 2006 Nov;189:459-60
pubmed: 17077438
J Clin Endocrinol Metab. 2006 Jun;91(6):1995-2010
pubmed: 16720669
Expert Rev Clin Pharmacol. 2018 Apr;11(4):439-458
pubmed: 29505313
Andrology. 2015 Sep;3(5):876-81
pubmed: 26216452
Arch Gen Psychiatry. 1987 Jun;44(6):573-88
pubmed: 3579504
Genet Med. 2011 Nov;13(11):966-72
pubmed: 21799429
World Psychiatry. 2006 Jun;5(2):71-6
pubmed: 16946938
Maturitas. 2002 Dec 10;43(4):231-7
pubmed: 12468130
J Pediatr. 2017 Jun;185:193-199.e4
pubmed: 28285751
Lancet. 2004 Jul 17-23;364(9430):273-83
pubmed: 15262106
World J Mens Health. 2013 Aug;31(2):103-25
pubmed: 24044106
Aging Male. 2003 Jun;6(2):86-93
pubmed: 12898792
J Endocrinol Invest. 2020 Dec;43(12):1675-1687
pubmed: 32567016
Genet Med. 2011 Jul;13(7):632-42
pubmed: 21546843
Endocr Pract. 1998 Jan-Feb;4(1):17-22
pubmed: 15251759
J Sex Med. 2018 Sep;15(9):1260-1271
pubmed: 30145097
Arch Gen Psychiatry. 1993 Dec;50(12):975-90
pubmed: 8250684
Schizophr Res. 2002 Mar 1;54(1-2):67-75
pubmed: 11853980
Am J Med Genet A. 2008 Mar 15;146A(6):708-19
pubmed: 18266239
Lancet. 2007 Sep 8;370(9590):859-77
pubmed: 17804063
J Endocrinol Invest. 2019 Jul;42(7):833-842
pubmed: 30499012
J Sex Med. 2015 Dec;12(12):2413-24
pubmed: 26612786
Psychopharmacol Bull. 1993;29(2):321-6
pubmed: 8290681
J Clin Endocrinol Metab. 1996 Oct;81(10):3654-62
pubmed: 8855818
Genet Med. 2018 Feb;20(2):214-222
pubmed: 28726803
Neurology. 2000 Jun 27;54(12):2218-23
pubmed: 10881243
J Endocrinol Invest. 2017 Feb;40(2):123-134
pubmed: 27644703
J Sex Med. 2013 Jun;10(6):1612-27
pubmed: 23551886
Asian J Androl. 2014 Mar-Apr;16(2):185-91
pubmed: 24407186
Clin Genet. 1988 Apr;33(4):262-9
pubmed: 3359683
Andrologia. 2006 Apr;38(2):48-53
pubmed: 16529575
Patient Educ Couns. 2015 Jan;98(1):90-5
pubmed: 25239793
Mayo Clin Proc. 2015 Aug;90(8):1104-15
pubmed: 26205546
J Health Soc Behav. 1980 Sep;21(3):219-39
pubmed: 7410799
J Clin Endocrinol Metab. 2005 Dec;90(12):6516-22
pubmed: 16204366
J Am Geriatr Soc. 2003 Jan;51(1):101-15; discussion 115
pubmed: 12534854
Dev Disabil Res Rev. 2009;15(4):284-94
pubmed: 20014369
Neuropsychologia. 2001;39(13):1385-94
pubmed: 11585606
Maturitas. 2005 Feb 14;50(2):124-33
pubmed: 15653010